BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 36547823)

  • 1. A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing.
    Saber Sichani A; Ranjbar M; Baneshi M; Torabi Zadeh F; Fallahi J
    Mol Biotechnol; 2023 Jun; 65(6):849-860. PubMed ID: 36547823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.
    Anzalone AV; Koblan LW; Liu DR
    Nat Biotechnol; 2020 Jul; 38(7):824-844. PubMed ID: 32572269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prime editing in plants and mammalian cells: Mechanism, achievements, limitations, and future prospects.
    Hillary VE; Ceasar SA
    Bioessays; 2022 Sep; 44(9):e2200032. PubMed ID: 35750651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prime editing: Its systematic optimization and current applications in disease treatment and agricultural breeding.
    Yu X; Huo G; Yu J; Li H; Li J
    Int J Biol Macromol; 2023 Dec; 253(Pt 4):127025. PubMed ID: 37769783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boosting targeted genome editing using the hei-tag.
    Thumberger T; Tavhelidse-Suck T; Gutierrez-Triana JA; Cornean A; Medert R; Welz B; Freichel M; Wittbrodt J
    Elife; 2022 Mar; 11():. PubMed ID: 35333175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing.
    Tao J; Bauer DE; Chiarle R
    Nat Commun; 2023 Jan; 14(1):212. PubMed ID: 36639728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New advances in CRISPR/Cas-mediated precise gene-editing techniques.
    Richardson C; Kelsh RN; J Richardson R
    Dis Model Mech; 2023 Feb; 16(2):. PubMed ID: 36847161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
    Bloomer H; Khirallah J; Li Y; Xu Q
    Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic Principles and Clinical Applications of CRISPR-Based Genome Editing.
    Lim JM; Kim HH
    Yonsei Med J; 2022 Feb; 63(2):105-113. PubMed ID: 35083895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough in CRISPR/Cas system: Current and future directions and challenges.
    Ali A; Zafar MM; Farooq Z; Ahmed SR; Ijaz A; Anwar Z; Abbas H; Tariq MS; Tariq H; Mustafa M; Bajwa MH; Shaukat F; Razzaq A; Maozhi R
    Biotechnol J; 2023 Aug; 18(8):e2200642. PubMed ID: 37166088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvements in the genetic editing technologies: CRISPR-Cas and beyond.
    Mingarro G; Del Olmo ML
    Gene; 2023 Feb; 852():147064. PubMed ID: 36435506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CRISPR/Cas-mediated DNA base editing technology and its application in biomedicine and agriculture].
    Yu C; Mo J; Zhao X; Li G; Zhang X
    Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3071-3087. PubMed ID: 34622618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research.
    Li ZH; Wang J; Xu JP; Wang J; Yang X
    Mil Med Res; 2023 Mar; 10(1):12. PubMed ID: 36895064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing.
    Hou Y; Ureña-Bailén G; Mohammadian Gol T; Gratz PG; Gratz HP; Roig-Merino A; Antony JS; Lamsfus-Calle A; Daniel-Moreno A; Handgretinger R; Mezger M
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prime Editing in Mammals: The Next Generation of Precision Genome Editing.
    Wang D; Fan X; Li M; Liu T; Lu P; Wang G; Li Y; Han J; Zhao J
    CRISPR J; 2022 Dec; 5(6):746-768. PubMed ID: 36512351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo application of base and prime editing to treat inherited retinal diseases.
    Jo DH; Bae S; Kim HH; Kim JS; Kim JH
    Prog Retin Eye Res; 2023 May; 94():101132. PubMed ID: 36241547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current advances in overcoming obstacles of CRISPR/Cas9 off-target genome editing.
    Aquino-Jarquin G
    Mol Genet Metab; 2021; 134(1-2):77-86. PubMed ID: 34391646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tools for Efficient Genome Editing; ZFN, TALEN, and CRISPR.
    Shamshirgaran Y; Liu J; Sumer H; Verma PJ; Taheri-Ghahfarokhi A
    Methods Mol Biol; 2022; 2495():29-46. PubMed ID: 35696026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.